Addex Therapeutics Ltd (SWX:ADXN)
0.0430
+0.0030 (7.50%)
Jul 10, 2026, 5:30 PM CET
Addex Therapeutics Employees
Addex Therapeutics had 3 employees as of December 31, 2025. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
36.50K CHF
Profits / Employee
-2.32M CHF
Market Cap
5.13M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 1 | 50.00% |
| Dec 31, 2024 | 2 | -21 | -91.30% |
| Dec 31, 2023 | 23 | -1 | -4.17% |
| Dec 31, 2022 | 24 | -2 | -7.69% |
| Dec 31, 2021 | 26 | -1 | -3.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bachem Holding AG | 2,595 |
| Idorsia | 487 |
| Basilea Pharmaceutica AG | 189 |
| Molecular Partners AG | 134 |
| Santhera Pharmaceuticals Holding AG | 94 |
| BioVersys AG | 33 |
| Newron Pharmaceuticals | 27 |
| Xlife Sciences AG | 20 |
Addex Therapeutics News
- 4 days ago - Addex Therapeutics (ADXN) Reveals Promising Preclinical Results on Sleep-Wake Regulation - GuruFocus
- 4 days ago - Addex Research Highlights MGlu7 Modulation As A Novel Pathway In Sleep And Stress Regulation - Nasdaq
- 4 days ago - Addex Therapeutics announces publication of new ADX71743 preclinical research - TheFly
- 17 days ago - Addex Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 17 days ago - Addex Therapeutics Quarterly report: Q1 2026 - Filings
- 17 days ago - Addex Therapeutics Earnings release: Q1 2026 - Filings
- 17 days ago - Addex Therapeutics Releases Q1 2026 Financial Results - AlphaStreet
- 18 days ago - Addex Records Wider Net Loss Of $1.7 Mln; Advances NTX-253 In Phase 1 For Schizophrenia - Nasdaq